Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting

References

1. 1.↵
   Substance Abuse and Mental Health Services Administration. Disaster Planning Handbook for Behavioral Health Treatment Programs. Technical Assistance Publication (TAP) Series 34. HHS Publication No. (SMA) 13-4779. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
2. 2.↵
   US Department of Justice Drug Enforcement Administration. COVID-19 Information Page. 2020.Available at: https://www.deadiversion.usdoj.gov/coronavirus.html. Accessed March 28, 2020.
3. 3.↵
   US Department of Health and Human Services. Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency. 2020. Available at: https://www.hhs.gov/hipaa/for-professionals/special-topics/emergency-preparedness/notification-enforcement-discretion-telehealth/index.html. Accessed March 28, 2020.
4. 4.↵
   1. Zheng W,
   2. Nickasch M,
   3. Lander L,
   4. et al

   . Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. J Addict Med 2017;11:138–44.

   OpenUrl
5. 5.↵
   1. Hilty DM,
   2. Ferrer DC,
   3. Parish MB,
   4. Johnston B,
   5. Callahan EJ,
   6. Yellowlees PM

   . The effectiveness of telemental health: a 2013 review. Telemed J E Health 2013;19:444–54.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Yang YT,
   2. Weintraub E,
   3. Haffajee RL

   . Telemedicine’s role in addressing the opioid epidemic. Mayo Clin Proc 2018;93:1177–80.

   OpenUrl
7. 7.↵
   1. Eibl JK,
   2. Gauthier G,
   3. Pellegrini D,
   4. et al

   . The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug Alcohol Depend 2017;176:133–8.

   OpenUrlPubMed